Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pfizer teams up with Biocon for diabetes biosimilars; deal ends

Executive Summary

In the largest deal ever by an Indian biotech, Biocon Ltd. has granted Pfizer Inc. an exclusive license--except in Germany, India, and Malaysia where rights are co-exclusive--to biosimilar versions of the recombinant human insulin analogs glargine, aspart, and lispro.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
Deal Status
  • Terminated
Deal Type
  • Alliance
    • R+D and Marketing-Licensing

Related Companies